EISAI LAUNCHES SNAIL VENOM PAIN DRUG IN BRITAIN

A new pain drug based on the venom of a deadly sea snail was launched in Britain on Monday, offering hope to patients with chronic pain who do not respond to or cannot tolerate treatments like morphine. Japanese drugmaker Eisai Co Ltd, which acquired European rights to Prialt from Ireland's Elan Corp Plc, is marketing the medicine first in Britain before rolling it out in other European markets.

BBC News (http://abcnews.go.com/Technology/wireStory?id=2171729)